Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from ...
"Shawbrook’s PE owners eye £2bn IPO" was originally created and published by Leasing Life, a GlobalData owned brand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback